Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
American Regent Animal Health has signed an exclusive agreement with UK firm Animalcare to relaunch Adequan i.m. in Europe.
Founded in 1979, Dyadic International has applied its enzyme-based innovation to multiple industries. Now, the firm is turning its attentions more to the animal health space. Animal Pharm editor Joseph Harvey spoke to the company's founder and chief executive Mark Emalfarb, as well as chief commercial officer Mathew Jones, to find out more.
Canadian pharmaceutical films specialist IntelGenx has ventured into the animal health sector for the first time with a deal for its VetaFilm platform.
Review 2019: US witnesses bumper year of veterinary approvals, while EU achieves milestone authorizations
In 2019, both the US and Europe saw several significant approvals in animal health. Animal Pharm analyst Sian Lazell gives an overview of the most notable products that were given the green light for their commercial debuts during the year.
Australian firm CannPal Animal Therapeutics has agreed a licensing agreement with the Commonwealth Scientific and Industrial Research Organisation (CSIRO).
Canadian firm Kane Biotech has fulfilled the first major order for its bluestem pet oral care line in China.
Canada's Angany is teaming up with animal health consultancy LEVOYA to help grow its veterinary immunotherapy pipeline.
Canada's Avivagen is working with the research subsidiary of Cofco Biotechnology on the regulatory process for OxC-beta Livestock in China.
A pipeline candidate from Australian biotechnology firm Zoono Group has shown to be effective against African swine fever (ASF).
Elanco has recalled certain batches of Rumensin in Australia due to an error on the product's label.
Kindred Biosciences' Mirataz has become the first product approved in Europe to treat cats with poor appetite resulting from chronic medical conditions.
A consumer group has expressed concern regarding the increase in sales of medically important antimicrobials for food animals in the US.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.